Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Gotto Antonio M Jr Md d Phil, Director. Insider active across 1 company, notably Esperion Therapeutics, Inc.. In total, 3 disclosures have been published. Activity tracked since 27 May 2021. The latest transaction was filed on 23 May 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Antonio M. Gotto Jr, MD D Phil is a Director at Esperion Therapeutics, Inc. In this role, he participates in the governance and oversight of the company's activities. Esperion is a biopharmaceutical company. Antonio brings expertise in research and development as well as corporate strategy.